Cancer News and Research

Latest Cancer News and Research

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

As tumor cells multiply, they often spawn tens of thousands of genetic mutations. Figuring out which ones are the most promising to target with immunotherapy is like finding a few needles in a haystack.

9 Oct 2019

Countries propose ban on e-cigarettes amid concerns about harmful health effects

A string of deaths in the United States linked to the use of electronic cigarettes has stirred concern worldwide about their growing popularity among young people and the health risks they pose to millions of users.

9 Oct 2019

New brain imaging study debunks controversial theory about dyslexia

New brain imaging research debunks a controversial theory about dyslexia that can impact how it is sometimes treated, Georgetown University Medical Center neuroscientists say.

9 Oct 2019

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

An Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome, also known as the "dark matter" of human cancer DNA.

9 Oct 2019

UNC Lineberger researcher receives grant to develop effective health warnings for little cigars, cigarillos

The National Cancer Institute has awarded University of North Carolina Lineberger Comprehensive Cancer Center researcher Adam Goldstein, MD, MPH, a five-year, $2.7 million grant to develop more effective health warnings for little cigars and cigarillos.

9 Oct 2019

More sensitive electrophysiology tools needed to study cancer cell populations

Bioelectricity of Cancer, a special issue of the peer-reviewed journal Bioelectricity, has just been published. Two promising discoveries are well delineated: an ultra-sensitive tool to detect cancer and a new therapeutic target for cancer immunotherapy.

9 Oct 2019

New blood test could help hasten the diagnosis of brain tumors

A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.

9 Oct 2019

Chemists employ new strategy to synthesize complex natural products

Chemists from the University of Basel have succeeded in synthesizing two complex natural products from the group of dithiodiketopiperazines (DTPs).

9 Oct 2019

Insilico and CTFH team up to expedite first-in-class therapeutics using AI platform

Insilico Medicine, a company developing an end-to-end drug discovery pipeline utilizing the latest advances in deep learning, has entered into a two-program research collaboration agreement with Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd..

9 Oct 2019

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

In Germany alone there are around 400,000 patients who suffer from chronic inflammatory bowel diseases. For the first time, researchers at Universitätsklinikum Erlangen have discovered that dysfunctions in blood vessels play a significant role in the development of such diseases.

9 Oct 2019

Chemists successfully synthesize complex natural products

Chemists from the University of Basel have succeeded in synthesizing two complex natural products from the group of dithiodiketopiperazines (DTPs). For this, they employed a new strategy based on "C-H bond activation," resulting in a short and high yielding route.

9 Oct 2019

Scientists demonstrate potential method for treating advanced liver cancers

Liver cancer is the second leading cause of cancer-related deaths worldwide. The most common primary liver cancer in adults is known as hepatocellular carcinoma (HCC), and accounts for approximately 780,000 deaths every year.

9 Oct 2019

Unique immune cell linked to remission in patients with triple negative breast cancer

A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London.

From The Francis Crick Institute 9 Oct 2019

Lab-grown, testosterone-producing cells could help treat hypogonadism

Researchers have managed to grow human, testosterone-producing cells, which could lead to improved treatment options for low testosterone levels.

9 Oct 2019

Cedars-Sinai breast radiologist explains benefits of 3D mammography for every woman

If it's October, it's Breast Cancer Awareness Month, when pink ribbons sprout up on everything from suit lapels to yogurt containers, reminding women to turn their attention to breast health -- especially mammograms.

9 Oct 2019

Statin use linked with lower risk of developing prostate cancer

In a study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer.

9 Oct 2019

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy.

9 Oct 2019

IU research examines trends in public perceptions of violence in people with mental illness

In response to recent mass shootings and consistent public outcry, President Donald Trump's administration is considering a controversial proposal to monitor people with mental illness in hopes of preventing mass shootings.

8 Oct 2019

Hormone therapy worsens quality of life in women with breast cancer

Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients.

8 Oct 2019

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive. However, after treatment, patients are at a small but real risk of developing a new cancer, called a second primary cancer.

8 Oct 2019

Cancer News and Research

Latest Cancer News and Research

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

Countries propose ban on e-cigarettes amid concerns about harmful health effects

New brain imaging study debunks controversial theory about dyslexia

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

UNC Lineberger researcher receives grant to develop effective health warnings for little cigars, cigarillos

More sensitive electrophysiology tools needed to study cancer cell populations

New blood test could help hasten the diagnosis of brain tumors

Chemists employ new strategy to synthesize complex natural products

Insilico and CTFH team up to expedite first-in-class therapeutics using AI platform

Dysfunctions in blood vessels contribute to the development of chronic inflammatory bowel diseases

Chemists successfully synthesize complex natural products

Scientists demonstrate potential method for treating advanced liver cancers

Unique immune cell linked to remission in patients with triple negative breast cancer

Lab-grown, testosterone-producing cells could help treat hypogonadism

Cedars-Sinai breast radiologist explains benefits of 3D mammography for every woman

Statin use linked with lower risk of developing prostate cancer

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

IU research examines trends in public perceptions of violence in people with mental illness

Hormone therapy worsens quality of life in women with breast cancer

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in